Status:
RECRUITING
Artificial Intelligence (AI) Assisted Real-time Adenoma Detection and Classification During Colonoscopies
Lead Sponsor:
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborating Sponsors:
McGill University
University of British Columbia
Conditions:
Artificial Intelligence
Eligibility:
All Genders
45-89 years
Phase:
NA
Brief Summary
This is a pragmatic, double-blind, randomized, controlled trial, to evaluate the effect of implementing a Computer-assisted detection (CADe) system within the routine clinical practice of Canadian hea...
Detailed Description
This trial will be conducted in four centers across Canada. All patients who meet the in/exclusion criteria can be enrolled. The patient's personal medical history will be reviewed to verify patient i...
Eligibility Criteria
Inclusion
- indication of undergoing a screening, surveillance, or diagnostic colonoscopy
- Age 45-89 years
Exclusion
- Patients undergoing emergency colonoscopy
- Patients with a known familial polyposis syndrome or a known inflammatory bowel disease
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
1596 Patients enrolled
Trial Details
Trial ID
NCT05244278
Start Date
August 1 2023
End Date
January 1 2027
Last Update
March 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Universitaire de Montréal
Montreal, Quebec, Canada